SEARCH

HOME / SEARCH / Nelarabine

iGMDRD233

Canonical SMILES: COC1=NC(=NC2=C1N=CN2C3C(C(C(O3)CO)O)O)N

InChI: InChI=1S/C11H15N5O5/c1-20-9-5-8(14-11(12)15-9)16(3-13-5)10-7(19)6(18)4(2-17)21-10/h3-4,6-7,10,17-19H,2H2,1H3,(H2,12,14,15)/t4-,6-,7+,10-/m1/s1

InChI Key: IXOXBSCIXZEQEQ-UHTZMRCNSA-N

Standard Name	CHEMBL	Pubchem CID	KEGG Drug ID	DRUGBANK ID	Drug Status	Drug targets (TTD)	Drug Type
Nelarabine	CHEMBL1201112	3011160	D05134	DB01280	Alone	DAP000985	Small Molecule

Drug Class:

Antimetabolites Antineoplastic Agents Antineoplastic and Immunomodulating Agents Carbohydrates Glycosides Immunosuppressive Agents Myelosuppressive Agents Nucleic Acids, Nucleotides, and Nucleosides Nucleoside Metabolic Inhibitor Nucleosides Purine Analogues

Drug Targets:

DNA POLA1 (P09884)

Drug Synonyms:

Nelarabine (JAN/USAN/INN)Nelzarabine (USAN)Arranon (TN)

Drug-model tissue-cancer distribution: Bubble Plot

Drug-gene pathway enrichments

Drug-gene GO enrichments

Drug-Gene: Aster Plot

Gene ID	Gene Name	Model Num.
22978	NT5C2	3

Gene in drug-gene network: Network Plot

Models in Nelarabine

SITE

DATATYPES

CLASSFICATION

Disclaimer: iGMDR is intended for research purposes only. Its information cannot be used for emergencies or medical or professional advice.